| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |